Sort   by:  
 Page size 
UnknownImmunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables.
Not available
S-EPMC6280511 | biostudies-literature
UnknownSex-Specific Differences in Primary CNS Lymphoma.
Not available
S-EPMC7352658 | biostudies-literature
UnknownCombined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.
Not available
S-EPMC6965118 | biostudies-literature
Genomicsena-DATASET-EORTC-22-06-2015-15:48:20:114-204 - samples
Data represent genome-wide DNA methylation profiles obtained by MethylCap-seq (Diagenode’s MethylCap-kit based purification followed by Illumina GAIIx sequencing), for 70 brain tissue samples, including 65 glioblastoma samples and 5 non-tumoral tissues (obtained from epilepsy surgery).
EGAD00001001399 | EGA
GenomicsGenome-wide DNA-methylation assessment by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
DNA-methylation is an important epigenetic feature in health and disease. Two cost-efficient genome-scale methodologies to assess DNA-methylation are MethylCap-seq and Illumina's Infinium HumanMethylation450 BeadChips (HM450). However, objective information regarding the best-suited methodology for ...
EGAS00001001191 | EGA
GenomicsEORTC Data Sharing DAC
Data Access Committee EGAC00001001818
EGAC00001001818 | EGA
UnknownThe DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.
Not available
S-EPMC6181207 | biostudies-literature
UnknownAlternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Not available
S-EPMC11889718 | biostudies-literature
Sort   by:  
 Page size